A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Sponsor: Eli Lilly and Company
Philadelphia, PA · +41 more sites
11 recruiting alzheimer's disease studies with a site in Philadelphia, PA.
All trials in Philadelphia, PA · All Alzheimer's Disease trials
Sponsor: Eli Lilly and Company
Philadelphia, PA · +41 more sites
Sponsor: Celgene
Philadelphia, PA · +59 more sites
Sponsor: University of Pennsylvania
Philadelphia, PA
Sponsor: University of Michigan
Philadelphia, PA · Pittsburgh, PA · +5 more sites
Sponsor: University of Pennsylvania
Philadelphia, PA · +1 more sites
Sponsor: University of Pennsylvania
Philadelphia, PA
Sponsor: University of Pennsylvania
Philadelphia, PA
Sponsor: Eidos Therapeutics, a BridgeBio company
Philadelphia, PA · Pittsburgh, PA · +38 more sites
Sponsor: GAP Innovations, PBC
Philadelphia, PA · +21 more sites
Sponsor: University of Pennsylvania
Philadelphia, PA
Sponsor: University of Pennsylvania
Philadelphia, PA · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.